Biggest News Aggregation in the World
📰 Orphan News

Page 84 - Orphan News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Orphan. Real-time updates on events, politics, business and more.

NCPCR writes to states, UTs over issue of children orphaned due to COVID-19

NCPCR writes to states, UTs over issue of children orphaned due to COVID-19 ANI | Updated: May 03, 2021 13:17 IST New Delhi [India], May 3 (ANI): National Commission for Protection of Child Rights (NCPCR) has written a letter to the chief secretary of all states and union territories regarding the issue of children who have become orphan due to the death of both parents due to COVID-19. The commission has requested that if any such information for an abando...
New Delhi National Commission For Protection Of Child Rights Child Welfare Committee Commission For Protection Of Child Rights National Commission Child Rights
Source: aninews.in

MitoChem Therapeutics, Inc.: MitoChem Therapeutics Granted FDA Orphan Drug Designation for Treatment of Retinitis Pigmentosa

MitoChem Therapeutics, Inc.: MitoChem Therapeutics Granted FDA Orphan Drug Designation for Treatment of Retinitis Pigmentosa CHARLESTON, SC / ACCESSWIRE / April 14, 2021 / MitoChem Therapeutics, Inc., a privately held company developing therapies for diseases involving mitochondrial dysfunction, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation status to its lead compound, MC16, for treatment of retinitis pigmentosa (RP). Retinitis pigmentosa i...
Michael Voevodsky Kostenloser Wertpapierhandel Craig Beeson Drug Designation Program Mitochem Therapeutics Inc Drug Administration

Gan & Lee receives EMA orphan drug designation for Phase I drug [...] | Comunicati stampa CataniaOggi

06 aprile 2021 13:40 Fonte: Adnkronos #salute-e-benessere - BEIJING, and BRIDGEWATER, N.J., April 6, 2021 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), a global biopharmaceutical company, today announced that the European Medicine Agency (EMA) Committee for Orphan Medicinal Products granted orphan drug designation for the investigational compound GLR2007, for the treatment of glioma. Glioma is a broad term describing neuroe...
Gina Antonucci Michelle Mazuranic Head Of Global Medical Affairs Committee For Orphan Medicinal Products Gan Lee Pharmaceuticals Co Ltd European Union

'PDM is a political orphan'

Top Story March 17, 2021 ISLAMABAD: Minister for Science and Technology Fawad Chaudhry said on Tuesday the government was working on initiation of contempt of court proceedings against the Election Commission of Pakistan (ECP) if it did not tender resignation. He was briefing the media about the decisions taken at the cabinet meeting here, which met with Prime Minister Imran Khan in the chair after the election of the chairman and deputy chairman of Senate. The minister said consultations were...
Ali Muhammad Nawaz Sharif Aftab Sherpao Awais Noorani Muslim League Nawaz Imran Khan

Sangamo Therapeutics, Inc.: Sangamo Announces EMA Releases Details Supporting Orphan Designation for BIVV003 for the Treatment of Sickle Cell Disease

(3) Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the European Medicines Agencys Committee for Orphan Medicinal Products (COMP) released details supporting the Orphan Designation of BIVV003, an investigational ex vivo gene-edited cell therapy product candidate currently being evaluated for the treatment of sickle cell disease in the Phase 1/2 PRECIZN-1 study partnered with Sanofi. The Committees decision to grant Orphan Designation was based in par...
Aaron Feingold Exchange Commission Sangamo Therapeutics Inc Sangamo Therapeutics European Medicines Agency Orphan Medicinal Products

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Ministry of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Anti-Cancer Agent Lenvima (Lenvatinib) With Prospective Indication for Uterine Body Cancer

(1) TOKYO, Mar 12, 2021 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has received orphan drug designation for LENVIMA (generic name: lenvatinib mesylate), the orally available multiple receptor kinase inhibitor discovered by Eisai, with a prospective indication for uterine body cancer, by the Ministry of Health, Labour and Welfare (MHLW). In Japan, the estimated number of patients with uterine body cancer is approximately 30,000.1 It is estimated that in 2020, there were more than...
United States Kostenloser Wertpapierhandel Merck Co Inc Eisai Co Ltd Ministry Of Health Public Relations Department

Caledonia family's 'pride and joy' lives overseas: They've been sponsoring Ukrainian orphans for 15 years

About 15 years ago, Caledonia residents Kam and William Buhler decided they wanted to help people outside of their family — far, far outside of their family. They have two daughters: one who was a teenager and another in her 20s at the time. But they wanted to do something more to help struggling teenagers overseas. In 2004 or 2005, Kam Buhler read a news article about an American who sponsored children in Ukraine. Buhler, who likes to travel but had never been to Ukraine before, wanted to...
United States Hong Kong Odes Ka Oblast Mikhail Misha Pozhar Vyacheslav Slava Koval Kam Buhler

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science